跳转至内容
Merck
CN

主要文件

查看所有文档

HMC0002

MISSION® miRNA，阴性对照1

Sequence from Arabidopsis thaliana with no homology to human gene sequences

别名:

成熟序列：GGUUCGUACGUACACUGUUCA

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.51
UNSPSC Code:
12352200
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

product line

MISSION®

form

solid

storage temp.

−20°C

General description

MISSION® miRNA阴性对照是任何miRNA实验的重要组成部分。 使用阴性对照可使研究人员创建mRNA敲低效率的基线。 阴性对照经过仔细选择，与已知的人类基因序列没有已知的同源性。 阴性对照1基于拟南芥序列。

Application

MISSION® miRNA阴性对照1已被用作miRNA转染的阴性对照。

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192
Sun, L. et al.
The Journal of Pathology, 3, 364-377 (2011)
The Effects of Sequence Variation on Genome-wide NRF2 Binding--New Target Genes and Regulatory SNPs.
Kuosmanen SM et al.
Nucleic Acids Research, 44, 1760-1760 (2016)
Yumeng Wang et al.
Genome research, 27(7), 1112-1125 (2017-04-16)
RNA editing, a widespread post-transcriptional mechanism, has emerged as a new player in cancer biology. Recent studies have reported key roles for individual miRNA editing events, but a comprehensive picture of miRNA editing in human cancers remains largely unexplored. Here
查看所有相关文献

全球贸易项目编号

货号GTIN
HMC0002-5NMOL04061826762066